Table 4. Multivariate association of adiponectin levels with mixed plaques.
Mixed plaques | |||
estimate | 95% CI | p | |
Model 1* | −0.090 | −0.127 to −0.053 | <0.0001 |
Model 2† | −0.078 | −0.115 to −0.040 | <0.0001 |
Model 3‡ | −0.080 | −0.120 to −0.041 | <0.0001 |
Model 4§ | −0.083 | −0.126 to −0.039 | 0.0002 |
Model 5∥ | −0.087 | −0.132 to −0.042 | 0.0001 |
Estimate and 95% CI for decrease in the number of mixed plaques for an 1 µg/ml increase in serum adiponectin levels. Full model 5 (including all parameters) is shown in Table S2 of the supplement.
adjusted for age, sex and BMI.
adjusted for age, sex, BMI, hypertension, diabetes mellitus, smoking and family history of CAD.
adjusted for age, sex, BMI, hypertension, diabetes mellitus, smoking, family history of CAD, LDL-C, HDL-C, triglycerides and hsCRP levels.
adjusted for age, sex, BMI, hypertension, diabetes mellitus, smoking, family history of CAD, LDL-C, HDL-C, triglycerides, hsCRP levels and medication.
adjusted for age, sex, BMI, hypertension, diabetes mellitus, smoking, family history of CAD, LDL-C, HDL-C, triglycerides, hsCRP levels, medication and PAT volume.